1. Home
  2. YSG vs FOCL Comparison

YSG vs FOCL Comparison

Compare YSG & FOCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Yatsen Holding Limited

YSG

Yatsen Holding Limited

N/A

Current Price

$2.77

Market Cap

238.3M

ML Signal

N/A

FOCL

EDAP TMS S.A. American Depositary Shares

N/A

Current Price

$4.35

Market Cap

222.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
YSG
FOCL
Founded
2016
1979
Country
China
France
Employees
N/A
N/A
Industry
Package Goods/Cosmetics
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
238.3M
222.4M
IPO Year
2020
1998

Fundamental Metrics

Financial Performance
Metric
YSG
FOCL
Price
$2.77
$4.35
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
★ $8.60
AVG Volume (30 Days)
★ 85.5K
77.3K
Earning Date
11-16-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $70,527,000.00
Revenue This Year
$4.74
N/A
Revenue Next Year
$11.48
$34.10
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 1.63
52 Week Low
$2.15
$4.00
52 Week High
$9.06
$6.40

Technical Indicators

Market Signals
Indicator
YSG
FOCL
Relative Strength Index (RSI) 49.42 50.30
Support Level $2.64 $4.01
Resistance Level $3.09 $4.50
Average True Range (ATR) 0.18 0.22
MACD 0.03 0.06
Stochastic Oscillator 59.62 62.58

Price Performance

Historical Comparison
YSG
FOCL

About YSG Yatsen Holding Limited

Yatsen Holding Ltd is engaged in the retail business of beauty products, skincare items, and other cosmetic products. The group's principal operations are currently organized into three segments on a product category basis, namely Color Cosmetics Brands, Skincare Brands, and others. The company's majority of revenue is generated from sales of Color Cosmetics Brands. Geographically, company operates in PRC, Europe and US regions.

About FOCL EDAP TMS S.A. American Depositary Shares

Edap TMS SA, formerly known as FocalTherics, operates in the Robotic Focal Therapy industry. It develops, manufactures, and markets minimally invasive medical devices across various countries to treat various conditions using proprietary focused ultrasound technology. The company's flagship platform, Focal One Robotic HIFU, combines imaging, real-time treatment planning, robotic precision, and high intensity focused ultrasound (HIFU) technology. It is focused on expanding the clinical adoption of its patented focused ultrasound-based robotic therapy platforms through continued innovation, clinical evidence generation, physician education, and various market development initiatives.

Share on Social Networks: